1 / 1

SYNTHESIS OF P EPTIDE N UCLEIC A CID (PNA) OLIGOMERS AND THEIR CONJUGATES

SYNTHESIS OF P EPTIDE N UCLEIC A CID (PNA) OLIGOMERS AND THEIR CONJUGATES . Györgyi Kovács 1* , Zoltán Timár 1* , Zoltán Kupihár 1* , Zoltán Kele 1 , Péter Forgó 2 , Lajos Kovács 1*. University of Szeged, 1 Institute of Medicinal Chemistry, *Laboratory Of Nucleic Acid,

Michelle
Download Presentation

SYNTHESIS OF P EPTIDE N UCLEIC A CID (PNA) OLIGOMERS AND THEIR CONJUGATES

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. SYNTHESIS OF PEPTIDE NUCLEIC ACID (PNA) OLIGOMERS AND THEIR CONJUGATES Györgyi Kovács1* , Zoltán Timár 1* , Zoltán Kupihár 1* , Zoltán Kele 1, Péter Forgó 2, Lajos Kovács 1* University of Szeged, 1 Institute of Medicinal Chemistry, *Laboratory Of Nucleic Acid, 2 Department Of Organic Chemistry, 6720 Szeged, Dóm tér 8 Introduction Antisense and antigene effect  molecular biology and medicinal chemistry Advantage in vivo stability and strong hybridization disadvantage poor cellular uptake and low activity Possible solutionsPNA-peptide and PNA-oligonucleotide conjugates Schematic representation of PNA oligomers Synthesis of our own PNA monomers using Fmoc/acyl protecting groups, as they are compatibleboth with peptide and oligonucleotide synthesis protocols (conjugate). Aims Synthesis of PNA oligomers, PNA-peptide and PNA-oligonucleotide conjugates from our monomers Results Problems with the oligomer synthesis and the proposed solutions optimization of the coupling step (efficiency of coupling agents in solution phase): I. (HBTU/HOBt/DIPEA/Lutidine) < (HATU/ DIPEA/ Lutidine) < BET/ DIPEA < CMP/ DIPEA 76 %90 %98-99 % > 99 % Selection of the solid phase II. compatible with peptide and oligonucleotide synthesis, acyl and PNA removal in one step with aq. NH3 but: oligoethylene-glycol chains disturb the analysis TentaGel II.1. The mass spectra of PNAs, prepared on Tentagel, showed [M+70]+ions (not complete removal of Ibu) and valuessmaller than M+ II.2. to check the efficiency of the coupling and acyl protecting group removal (the most critical steps) Wang CPG II.3. Synthesis of the PNA-oligonucleotide conjugates III. removal of the acyl protecting group aq. NH3 order of stability: Ibu > An> 4-tBuBz H-Gly-(gIbu)5-Lys-OH 50 °C, ON PNA synthesis monomer : HATU: DIPEA: lutidine 3: 2.7:3.3:3.3 20minutes; DMF PNA-oligonucleotide conjugate Peptide-PNA conjugate PNA-linker2-5'-oligonucleotide- 3' H-Cys-ArgArgMetLysTrpLysLys-OH + H-Cys(Npys)-gIbuaAnaAnc4tBuBzaAntc4tBuBzaAntgIbugIbutc4tBuBzgIbut -Lys-OH 5'-oligonucleotide-3'-linker-PNA Financial support: OTKA T 022551 FKFP 0597/1999 linker Dr. Gyula Sági et al.

More Related